United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Apr 13, 2026 · Filed Apr 14, 2026

On Apr 13, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$574.88 for US$5.75M under a trading plan, leaving 18,876 shares. Filed Apr 14, 2026 (Form 4).

Sold
10,000 shares
Price
US$574.88 average (US$569.61 to US$580.03)
Value
US$5.75M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 13, 2026Common StockOption exercise10,000US$135.4228,876Direct
Apr 13, 2026Common StockSale40US$569.6128,836Direct
Apr 13, 2026Common StockSale281US$571.1428,555Direct
Apr 13, 2026Common StockSale1,154US$571.7627,401Direct
Apr 13, 2026Common StockSale1,210US$572.9626,191Direct
Apr 13, 2026Common StockSale1,860US$574.0024,331Direct
Apr 13, 2026Common StockSale1,457US$575.0622,874Direct
Apr 13, 2026Common StockSale1,354US$575.9621,520Direct
Apr 13, 2026Common StockSale1,603US$577.0119,917Direct
Apr 13, 2026Common StockSale601US$577.9319,316Direct
Apr 13, 2026Common StockSale400US$579.0418,916Direct
Apr 13, 2026Common StockSale40US$580.0318,876Direct

Source

View original at SEC

Related